Sign up Australia
Proactive Investors - Run By Investors For Investors

Viralytics Limited in ASX trading halt

Viralytics Limited in ASX trading halt

Viralytics Limited (ASX:VLA) is heading to market with a capital raising.

The ASX has granted the company a trading halt, with its shares placed in pre-open.

Earlier in the week Viralytics received $2.9 million from the Australian Taxation Office as a R&D claim for FY15.

Viralytics is focussed on the area of developing oncolytic immunotherapy treatments for a range of cancers.

The halt will last until the opening of trade on Monday 14th December 2015, or earlier if an announcement is made to the market.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full VLA profile View Profile

Viralytics Timeline

Related Articles

People working in a laboratory
May 02 2018
The benefits of Admedus' proprietary ADAPT technology and products are now scientifically proven beyond doubt.
1519933435_to-conceive-pic.jpg
March 01 2018
The health and wellbeing group, which has a broad product portfolio, had an eventful 2017,
spreadsheet and calculator
January 25 2018
According to one City number cruncher, Ergomed’s drugs safety unit alone is worth as much as the whole business

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use